Artificial Intelligence (AI) Stock Could Roar Back by 2026
A well-known AI stock has retraced roughly a quarter from its high, creating a potential entry point for investors. T...
Which Index Type Is Best For Passive Investing
Which index type is best for passive investing? This guide compares index types, costs, and tracking performance to help you pick the most efficient option.
23,556 articles
Reasons Wait Before Buying: 2 Holds, 1 Buy SpaceX Today
Investing in a high-flying name like SpaceX can spark excitement. This article breaks down two strong reasons to wait...
Healthcare Stock Soars This: Fund Lifts Stake to 10%
A leading home-health provider delivered a 74% rise over 12 months, while a prominent fund expanded its ownership to ...
Tencent Music Stock Tumbling: What Investors Should Know
A surprising stock move followed Tencent Music’s latest quarterly results, with growth overshadowed by a dip in users...
Forget Hype: International "Wide Moat" Stocks to Buy Now
When AI buzz dominates markets, smart investors look abroad for durable moats. This guide explains two international ...
Naya Capital Adds Masimo: A Deep Dive Into the Move
A notable fund adds Masimo stock, signaling confidence in noninvasive monitoring tech. This analysis breaks down the ...
Fort Baker Dumps 1.68 Million TEGNA Shares: What It Means
Fort Baker’s decision to liquidate its TGNA position signals shifting beliefs about the media stock. This guide break...
Jim Cramer Declares Himself an Idiot, Bets on Corning Rally
Cramer confronted his past mega-cap bets on Mad Money, pivoting to a bullish view on Corning as supplier demand remai...
Victoria’s Secret Stock $8.5 Million Bet Signals Turnaround
A fresh institutional stake has emerged in Victoria’s Secret stock this quarter. The $8.5 million bet suggests some m...
Thinking About Buying Swarmer? 3 Investor Essentials
The post-IPO market is buzzing about Swarmer, but excitement can blur judgment. Here are three practical realities ev...
Revolution Medicines Billion Market: Why the Valuation Makes Sense
A biotech with no current revenue can still carry a sky-high valuation. This article explains how Revolution Medicine...
Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status